Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | November 30, 2025 | December 02, 2025 |
| PROGRESSIVE CORP/OH/PGR · Entity 193 | Director | October 09, 2026 | October 13, 2026 |
| Wheels Up Experience Inc.UP · Entity 6501 | Director | June 09, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date November 30, 2025 · Filed December 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,438.4534 |
Reported balance
After 2025-11-30 transaction · row 1
1 source rowRow 1 · 2025-11-30 · Tax withholding · Disposed 9,748 · Balance 19,438.4534 F1: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
PROGRESSIVE CORP/OH/
Report date October 09, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Unit (rest. Stock)SEC Table II · derivative / convertible security | Direct | 155,758.3929 |
Reported balance
After 2026-10-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-09 · Grant · Acquired 71.2004 · Balance 155,758.3929 F1: 1 for 1. F2: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3: Expiration Date is the same as the Date Exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: 1 for 1.
F2: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan.
F3: Expiration Date is the same as the Date Exercisable.
Wheels Up Experience Inc.
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 24,305 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 24,305 · Balance 24,305 F1: Represents a grant of restricted stock units ("RSUs") under the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as amended by Amendment No. 1 thereto, effective April 15, 2024, Amendment No. 2 thereto, effective March 26, 2025, and Amendment No. 3 thereto, effective March 31, 2026), pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended. The RSUs will be settled in shares of Class A common stock, par value $0.0001 per share, of Wheels Up Experience Inc. (the "Issuer") upon vesting, if at all. The RSUs will vest in four equal quarterly installments on each of (i) September 9, 2026, (ii) December 9, 2026, (iii) March 9, 2027, and (iv) upon the earlier to occur of (a) June 9, 2027 or (b) the date of the next annual meeting of stockholders of the Issuer following June 9, 2027, in each case subject to the Reporting Person's continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units ("RSUs") under the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as amended by Amendment No. 1 thereto, effective April 15, 2024, Amendment No. 2 thereto, effective March 26, 2025, and Amendment No. 3 thereto, effective March 31, 2026), pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended. The RSUs will be settled in shares of Class A common stock, par value $0.0001 per share, of Wheels Up Experience Inc. (the "Issuer") upon vesting, if at all. The RSUs will vest in four equal quarterly installments on each of (i) September 9, 2026, (ii) December 9, 2026, (iii) March 9, 2027, and (iv) upon the earlier to occur of (a) June 9, 2027 or (b) the date of the next annual meeting of stockholders of the Issuer following June 9, 2027, in each case subject to the Reporting Person's continued service to the Issuer.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AETNA INC /PA/
Report date November 28, 2018 · Filed November 28, 2018
Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 1
1 source rowRow 1 · 2018-11-28 · Disposition to issuer · Disposed 3,000 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-11-28 · Disposition to issuer · Disposed 18,274.1882 · Balance 0 F2: Units accrued under the Non-Employee Director Compensation Plan (the "Plan") pursuant to deferral of Director Fees. These Units were canceled pursuant to the terms of the Plan in exchange for an amount (the "Unit Amount") in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-11-28 · Disposition to issuer · Disposed 6,000 · Balance 0 F3: Previously reported Units granted under the Plan. These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the Unit Amount. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-11-28 · Disposition to issuer · Disposed 990 · Balance 0 F4: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.. |
| Deferred Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-11-28 · Disposition to issuer · Disposed 33,730.2412 · Balance 0 F5: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
F2: Units accrued under the Non-Employee Director Compensation Plan (the "Plan") pursuant to deferral of Director Fees. These Units were canceled pursuant to the terms of the Plan in exchange for an amount (the "Unit Amount") in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.
F3: Previously reported Units granted under the Plan. These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the Unit Amount.
F4: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement..
F5: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.
TIFFANY & CO
Report date January 07, 2021 · Filed January 11, 2021
Section 16 reporting ended · disclosed 2021-01-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock $.01 ParSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 1
1 source rowRow 1 · 2021-01-07 · Disposition to issuer · Disposed 25,409 · Balance 0 F1: Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of October 28, 2020, by and among Tiffany & Co. (the "Company"), LVMH Moet Hennessy-Louis Vuitton SE ("Parent"), Breakfast Holdings Acquisition Corp. ("Holding") and Breakfast Acquisition Corp. ("Merger Sub") (the "Merger Agreement"), which amended and restated the Agreement and Plan of Merger, dated as of November 24, 2019, by and among the Company, Parent, Holding and Merger Sub, in exchange for $131.50 per share in cash, without interest and less any required withholding taxes (the "Per Share Merger Consideration"). The total number of shares disposed of included 10,355 unvested restricted stock units ("RSUs"), and 5,054 vested RSUs (which includes dividend equivalent units credited in respect of such vested RSUs) as to which the director elected to defer the maturity date (and thereby the delivery of the related shares). |
| Common Stock $.01 ParSEC Table I · non-derivative | IndirectBy Family Trust | 0 |
Reported balance
After 2021-01-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-01-07 · Disposition to issuer · Disposed 10,000 · Balance 0 F1: Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of October 28, 2020, by and among Tiffany & Co. (the "Company"), LVMH Moet Hennessy-Louis Vuitton SE ("Parent"), Breakfast Holdings Acquisition Corp. ("Holding") and Breakfast Acquisition Corp. ("Merger Sub") (the "Merger Agreement"), which amended and restated the Agreement and Plan of Merger, dated as of November 24, 2019, by and among the Company, Parent, Holding and Merger Sub, in exchange for $131.50 per share in cash, without interest and less any required withholding taxes (the "Per Share Merger Consideration"). The total number of shares disposed of included 10,355 unvested restricted stock units ("RSUs"), and 5,054 vested RSUs (which includes dividend equivalent units credited in respect of such vested RSUs) as to which the director elected to defer the maturity date (and thereby the delivery of the related shares). |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $93.53 · Expires 2029-06-04 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-01-07 · Disposition to issuer · Disposed 9,489 · Balance 0 F2: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $126.44 · Expires 2028-05-24 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-01-07 · Disposition to issuer · Disposed 8,395 · Balance 0 F2: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $85.82 · Expires 2027-05-25 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-01-07 · Disposition to issuer · Disposed 6,749 · Balance 0 F2: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of October 28, 2020, by and among Tiffany & Co. (the "Company"), LVMH Moet Hennessy-Louis Vuitton SE ("Parent"), Breakfast Holdings Acquisition Corp. ("Holding") and Breakfast Acquisition Corp. ("Merger Sub") (the "Merger Agreement"), which amended and restated the Agreement and Plan of Merger, dated as of November 24, 2019, by and among the Company, Parent, Holding and Merger Sub, in exchange for $131.50 per share in cash, without interest and less any required withholding taxes (the "Per Share Merger Consideration"). The total number of shares disposed of included 10,355 unvested restricted stock units ("RSUs"), and 5,054 vested RSUs (which includes dividend equivalent units credited in respect of such vested RSUs) as to which the director elected to defer the maturity date (and thereby the delivery of the related shares).
F2: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 13, 2026 15:05 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 71.2004 | $0.00 | $0.00 |
DisclosureSEC source: 0000080661-26-000361 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,758.3929 Underlying: Common · 71.2004 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| July 10, 2026 Filed Jul 14, 2026 15:35 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 67.7387 | $0.00 | $0.00 |
DisclosureSEC source: 0000080661-26-000257 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,687.1925 Underlying: Common · 67.7387 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 00:01 UTC | Wheels Up Experience Inc. UP · Entity 6501 | GrantClass A Common Stock, par value $0.0001 per share | 24,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-072473 · tm2617171-4_4seq1.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,305 F1 · shares: Represents a grant of restricted stock units ("RSUs") under the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as amended by Amendment No. 1 thereto, effective April 15, 2024, Amendment No. 2 thereto, effective March 26, 2025, and Amendment No. 3 thereto, effective March 31, 2026), pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended. The RSUs will be settled in shares of Class A common stock, par value $0.0001 per share, of Wheels Up Experience Inc. (the "Issuer") upon vesting, if at all. The RSUs will vest in four equal quarterly installments on each of (i) September 9, 2026, (ii) December 9, 2026, (iii) March 9, 2027, and (iv) upon the earlier to occur of (a) June 9, 2027 or (b) the date of the next annual meeting of stockholders of the Issuer following June 9, 2027, in each case subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 08, 2026 Filed May 12, 2026 15:18 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantCommon | 2,011 | $0.00 | $0.00 |
DisclosureSEC source: 0000080661-26-000189 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,011 F1 · kind: Restricted stock grant made pursuant to The Progressive Corporation Amended and Restated 2017 Directors Equity Incentive Plan, and which will vest on April 9, 2027. The Progressive Corporation allowed each director to indicate his or her preference to receive compensation for the 2026-2027 term in the form of 100% restricted stock or 60% restricted stock and 40% cash. The reporting person indicated a preference to receive compensation in the form of 100% restricted stock. After considering such preference, the Compensation and Talent Committee granted a restricted stock award representing 100% of the reporting person's compensation for the 2026-2027 term. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 15:45 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 79.091 | $0.00 | $0.00 |
DisclosureSEC source: 0000080661-26-000165 · form4.xml · derivative · entry 3 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,619.4537 Underlying: Common · 79.091 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1. F5 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 15:45 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 1,301 | $0.00 | $0.00 |
DisclosureSEC source: 0000080661-26-000165 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,540.3627 Underlying: Common · 1,301 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1. F3 · derivative.exercise_date: These units will be paid out in an equal number of Common Shares at the time elected by the reporting person or at such other time determined in accordance with the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 15:45 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | Disposition to issuerCommon | 1,301 | $0.00 | $0.00 |
DisclosureSEC source: 0000080661-26-000165 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The reporting person elected to defer receipt of previously granted restricted Common Shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 16:29 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 9,276.5299 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000080661-26-000034 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,239.3628 Underlying: Common · 9,276.5299 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| November 30, 2025 Filed Dec 2, 2025 22:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 9,748 | $80.36 | $783,349.28 |
DisclosureSEC source: 0000064803-25-000071 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,438.4534 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 23:39 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 60.0061 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000080661-25-000094 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,962.8329 Underlying: Common · 60.0061 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 15:21 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 58.6782 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-019158 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,902.8267 Underlying: Common · 58.6782 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| May 09, 2025 Filed May 12, 2025 21:00 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantCommon | 1,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013990 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,301 F1 · kind: Restricted stock grant made pursuant to The Progressive Corporation Amended and Restated 2017 Directors Equity Incentive Plan, and which will vest on April 10, 2026. The Progressive Corporation allowed each director to indicate his or her preference to receive compensation for the 2025-2026 term in the form of 100% restricted stock or 60% restricted stock and 40% cash. The reporting person indicated a preference to receive compensation in the form of 100% restricted stock. After considering such preference, the Compensation and Talent Committee granted a restricted stock award representing 100% of the reporting person's compensation for the 2025-2026 term. Read SEC document |
| April 11, 2025 Filed Apr 15, 2025 18:03 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 53.1199 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012034 · form4.xml · derivative · entry 3 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,844.1486 Underlying: Common · 53.1199 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1 F5 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 11, 2025 Filed Apr 15, 2025 18:03 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 1,715 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012034 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,791.0287 Underlying: Common · 1,715 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1 F3 · derivative.exercise_date: These units will be paid out in an equal number of Common Shares at the time elected by the reporting person or at such other time determined in accordance with the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 11, 2025 Filed Apr 15, 2025 18:03 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | Disposition to issuerCommon | 1,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012034 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The reporting person elected to defer receipt of previously granted restricted Common Shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. Read SEC document |
| January 16, 2025 Filed Jan 21, 2025 15:32 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 2,645.5623 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-001552 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,076.0287 Underlying: Common · 2,645.5623 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| November 30, 2024 Filed Dec 3, 2024 22:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 50,125 | $59.85 | $2,999,981.25 |
DisclosureSEC source: 0001127602-24-028491 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,125 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in two equal installments, commencing 11/30/2025. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 14:16 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 55.5237 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025441 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,430.4664 Underlying: Common · 55.5237 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 18:24 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GiftCommon | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020723 · form4.xml · nonDerivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,715 F2 · kind: Represents shares of the Issuer's common shares that the Reporting Person donated as a gift to a donor advised fund. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 18:24 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | SaleCommon | 5,039.3886 | $226.67 | $1,142,278.21 |
DisclosureSEC source: 0001127602-24-020723 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,215 F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $226.66 and $226.70, inclusive. The reporting person undertakes to provide to The Progressive Corporation, any security holder of The Progressive Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 13:36 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 65.9921 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020419 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,374.9428 Underlying: Common · 65.9921 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 5,302.5035 | $57.52 Strike: $0.00 | $305,000.00 |
DisclosureSEC source: 0001127602-24-015899 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,561.3323 Underlying: Common Stock · 5,302.5035 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 10, 2024 Filed May 14, 2024 15:11 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantCommon | 1,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015185 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,254.3886 F1 · kind: Restricted stock grant made pursuant to The Progressive Corporation Amended and Restated 2017 Directors Equity Incentive Plan, and which will vest on April 11, 2025. The Progressive Corporation allowed each director to indicate his or her preference to receive compensation for the 2024-2025 term in the form of 100% restricted stock or 60% restricted stock and 40% cash. The reporting person indicated a preference to receive compensation in the form of 100% restricted stock. After considering such preference, the Compensation and Talent Committee granted a restricted stock award representing 100% of the reporting person's compensation for the 2024-2025 term. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 18:33 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 67.9527 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012950 · form4.xml · derivative · entry 3 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,308.9507 Underlying: Common · 67.9527 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1 F5 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 18:33 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 2,549 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012950 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,240.998 Underlying: Common · 2,549 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1 F3 · derivative.exercise_date: These units will be paid out in an equal number of Common Shares at the time elected by the reporting person or at such other time determined in accordance with the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 18:33 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | Disposition to issuerCommon | 2,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012950 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,539.3886 F1 · price: The reporting person elected to defer receipt of previously granted restricted common shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 20:24 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 652.0779 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-002591 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,691.998 Underlying: Common · 652.0779 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 4,411.9774 | $69.13 Strike: $0.00 | $305,000.00 |
DisclosureSEC source: 0001127602-23-027831 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,639.0157 Underlying: Common Stock · 4,411.9774 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| October 13, 2023 Filed Oct 17, 2023 15:14 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantRestricted Stock Unit · Derivative | 89.7986 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025938 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,039.9201 Underlying: Common · 89.7986 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 18:58 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantRestricted Stock Unit · Derivative | 119.6148 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-020937 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,950.1215 Underlying: Common · 119.6148 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,917.1837 | $69.31 Strike: $0.00 | $271,500.00 |
DisclosureSEC source: 0001127602-23-016324 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,634.358 Underlying: Common Stock · 3,917.1837 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 12, 2023 Filed May 16, 2023 16:06 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantCommon | 2,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-015672 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,088.3886 F1 · kind: Restricted stock grant made pursuant to The Progressive Corporation Amended and Restated 2017 Directors Equity Incentive Plan, and which will vest on April 12, 2024. The Progressive Corporation allowed each director to indicate his or her preference to receive compensation for the 2023-2024 term in the form of 100% restricted stock or 60% restricted stock and 40% cash. The reporting person indicated a preference to receive compensation in the form of 100% restricted stock. After considering such preference, the Compensation Committee granted a restricted stock award representing 100% of the reporting person's compensation for the 2023-2024 term. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 18:46 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 99.778 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013074 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,830.5067 Underlying: Common · 99.778 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 16:40 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 3,098 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-012967 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,730.7287 Underlying: Common · 3,098 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1 F3 · derivative.exercise_date: These units will be paid out in an equal number of Common Shares at the time elected by the reporting person or at such other time determined in accordance with the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 16:40 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | Disposition to issuerCommon | 3,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-012967 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,539.3886 F1 · price: The reporting person elected to defer receipt of previously granted restricted common shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 17:41 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 100.2646 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-001559 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,632.7287 Underlying: Common · 100.2646 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,212.8937 | $94.93 Strike: $0.00 | $305,000.00 |
DisclosureSEC source: 0001127602-22-026170 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,574.897 Underlying: Common Stock · 3,212.8937 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| October 14, 2022 Filed Oct 18, 2022 20:22 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 111.4232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-024082 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,532.4641 Underlying: Common · 111.4232 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:29 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 115.6863 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019500 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,421.0409 Underlying: Common · 115.6863 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| May 16, 2022 Filed May 18, 2022 18:51 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantCommon | 3,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-014908 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,637.3886 F1 · kind: Restricted stock grant, made pursuant to The Progressive Corporation Amended and Restated 2017 Directors Equity Incentive Plan, and which will vest on April 13, 2023. The Progressive Corporation allowed each director to indicate his or her preference to receive compensation for the 2022-2023 term in the form of 100% restricted stock or 60% restricted stock and 40% cash. The reporting person indicated a preference to receive compensation in the form of 100% restricted stock. After considering such preference, the Compensation Committee granted a restricted stock award representing 100% of the reporting person's compensation for the 2022-2023 term. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,112.5625 | $97.99 Strike: $0.00 | $305,000.00 |
DisclosureSEC source: 0001127602-22-014466 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,083.7262 Underlying: Common Stock · 3,112.5625 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 15:58 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 118.837 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012047 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,305.3546 Underlying: Common · 118.837 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 17:55 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 3,090 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011806 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,186.5176 Underlying: Common · 3,090 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1. F3 · derivative.exercise_date: These units will be paid out in an equal number of Common Shares at the time elected by the reporting person, subject to the vesting provisions of the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 17:55 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | Disposition to issuerCommon | 3,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011806 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,539.3886 F1 · price: The reporting person elected to defer receipt of previously granted restricted common shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 19:04 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 118.9833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000080661-22-000034 · wf-form4_164261907693418.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,096.5176 Underlying: Common · 118.9833 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 20:53 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 1,847.9341 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-032052 · form4.xml · derivative · entry 6 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,977.5343 Underlying: Common · 1,847.9341 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1. F3 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or otherwise in accordance with the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,671.5195 | $92.73 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-21-029717 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,899.2283 Underlying: Common Stock · 1,671.5195 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| October 18, 2021 Filed Dec 30, 2021 20:53 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | OtherCommon | 8.3645 | $90.04 | $753.10 |
DisclosureSEC source: 0001127602-21-032052 · form4.xml · nonDerivative · entry 5 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,629.3886 F1 · kind: These shares were acquired upon the reinvestment of dividend equivalents in a broker-sponsored dividend reinvestment plan. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 21:43 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 140.5317 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027232 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,129.6002 Underlying: Common · 140.5317 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| July 16, 2021 Filed Dec 30, 2021 20:53 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | OtherCommon | 7.9216 | $94.97 | $752.31 |
DisclosureSEC source: 0001127602-21-032052 · form4.xml · nonDerivative · entry 4 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,621.0241 F1 · kind: These shares were acquired upon the reinvestment of dividend equivalents in a broker-sponsored dividend reinvestment plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.